344 Results for "

PDGFr-

" in MedChemExpress (MCE) Product Catalog:
Products (344)

344 Results for "PDGFr-" in MCE Product Catalog:

19
19 Cited Publications
Referencia número: HY-13223
No. CAS: 670220-88-9
Pureza:  99.67%
Synonyms: CP-868596
Target:  

FLT3 PDGFR Autophagy

Áreas de investigación:  

Cancer

Crenolanib is a potent and selective inhibitor of wild-type and mutant isoforms of the class III receptor tyrosine kinases FLT3 and PDGFRα/β with Kds of 0.74 nM and 2.1 nM/3.2 nM, respectively.
loading...
    loading...
19
19 Cited Publications
Referencia número: HY-13223A
No. CAS: 670220-93-6
Synonyms: CP 868596-26
Target:  

Autophagy PDGFR FLT3

Áreas de investigación:  

Cancer

Crenolanib benzenesulfonate is a potent and selective inhibitor of wild-type and mutant isoforms of the class III receptor tyrosine kinases FLT3 and PDGFRα/β with Kds of 0.74 nM and 2.1 nM/3.2 nM, respectively.
loading...
    loading...
14
14 Cited Publications
Referencia número: HY-10205
No. CAS: 288383-20-0
Pureza:  99.87%
Synonyms: AZD2171
Cediranib (AZD2171) is a highly potent, orally available and blood-brain barrier permeability VEGFR tyrosine kinase inhibitor with IC50s of <1, <3, 5, 5, 36, 2 nM for Flt1, KDR, Flt4, PDGFRα, PDGFRβ, c-Kit, respectively.
loading...
    loading...
14
14 Cited Publications
Referencia número: HY-13049
No. CAS: 857036-77-2
Pureza:  99.95%
Synonyms: AZD-2171 maleate
Target:  

VEGFR Autophagy PDGFR

Áreas de investigación:  

Cancer

Cediranib maleate (AZD-2171 maleate) is a highly potent, orally available VEGFR inhibitor with IC50s of <1, <3, 5, 5, 36, 2 nM for Flt1, KDR, Flt4, PDGFRα, PDGFRβ, c-Kit, respectively.
loading...
    loading...
14
14 Cited Publications
Referencia número: HY-10407
No. CAS: 215543-92-3
Pureza:  99.86%
Target:  

VEGFR FGFR PDGFR

Áreas de investigación:  

Cancer

SU 5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGFRβ, respectively.
loading...
    loading...
12
12 Cited Publications
Referencia número: HY-50905
No. CAS: 405169-16-6
Synonyms: CHIR-258; TKI258
Target:  

FLT3 c-Kit FGFR VEGFR PDGFR c-Fms

Áreas de investigación:  

Cancer

Dovitinib (CHIR-258) is an orally active, potent multi-targeted tyrosine kinase (RTK) inhibitor with IC50s of 1, 2, 36, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, CSF-1R, FGFR1/FGFR3, VEGFR1/VEGFR2/VEGFR3 and PDGFRα/PDGFRβ, respectively. Dovitinib has potent antitumor activity .
loading...
    loading...
12
12 Cited Publications
Referencia número: HY-10207
No. CAS: 692737-80-7
Pureza:  99.75%
Synonyms: CHIR-258 lactate; TKI-258 lactate
Target:  

FLT3 c-Kit FGFR VEGFR PDGFR

Áreas de investigación:  

Cancer

Dovitinib lactate (TKI258 lactate) is a multi-targeted tyrosine kinase inhibitor with IC50s of 1, 2, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, FGFR1/3, VEGFR1/2/3 and PDGFRα/β, respectively .
loading...
    loading...
8
8 Cited Publications
Referencia número: HY-116624
No. CAS: 163655-37-6
Pureza:  99.76%
Target:  

VEGFR Apoptosis

Áreas de investigación:  

Cancer

MAZ51 is a selective inhibitor of VEGFR-3 (Flt-4) tyrosine kinase. MAZ51 inhibits VEGF-C-induced activation of VEGFR-3 without blocking VEGF-C-mediated stimulation of VEGFR2. MAZ51 had no effect on ligand-induced autophosphorylation of EGFR, IGF-1R and PDGFRβ. MAZ51 blocks proliferation and induces apoptosis in a wide variety of tumor cells. Antitumor activity .
loading...
    loading...
7
7 Cited Publications
Referencia número: HY-138813
Pureza:  99.14%
Synonyms: SU-12662 hydrochloride
Target:  

Drug Metabolite

Áreas de investigación:  

Cancer

N-Desethyl Sunitinib (SU-12662) (hydrochloride) is a metabolite of sunitinib. Sunitinib is a potent, ATP-competitive VEGFR, PDGFRβ and KIT inhibitor with Ki values of 2, 9, 17, 8 and 4 nM for VEGFR -1, -2, -3, PDGFRβ and KIT, respectively .
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-10517
No. CAS: 252916-29-3
Pureza:  99.13%
Synonyms: SU6668; TSU-68
Target:  

PDGFR FGFR VEGFR Apoptosis

Áreas de investigación:  

Cancer

Orantinib (SU6668; TSU-68) is a multi-targeted receptor tyrosine kinase inhibitor with Kis of 2.1 μM, 8 nM and 1.2 μM for Flt-1, PDGFRβ and FGFR1, respectively.
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-15511
No. CAS: 10537-47-0
Pureza:  99.87%
Synonyms: Tyrphostin 9; Malonoben
Áreas de investigación:  

Infection Cancer

Tyrphostin A9, a PDGFR inhibitor, is a potent inducer of mitochondrial fission. Tyrphostin A9 emerged as the most potent and selective of 51 tyrosine kinase inhibitors tested against the TNF-induced respiratory burst. Tyrphostin A9 has anti-influenza virus activities.
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-10206
No. CAS: 850879-09-3
Pureza:  99.40%
Synonyms: MP470; HPK 56
Áreas de investigación:  

Cancer

Amuvatinib (MP470) is an orally bioavailable multi-targeted tyrosine kinase inhibitor with potent activity against mutant c-Kit, PDGFRα, Flt3, c-Met and c-Ret. Amuvatinib (MP470) is also a DNA repair suppressor through suppression of DNA repair protein RAD51, thereby disrupting DNA damage repair . Antineoplastic activity .
loading...
    loading...
5
5 Cited Publications
Referencia número: HY-50751
No. CAS: 796967-16-3
Synonyms: ABT-869; AL-39324
Áreas de investigación:  

Inflammation/Immunology Cancer

Linifanib (ABT-869) is a potent and orally active multi-target inhibitor of VEGFR and PDGFR family with IC50s of 4, 3, 66, and 4 nM for KDR, FLT1, PDGFRβ, and FLT3, respectively. Linifanib shows prominent antitumor activity. Linifanib has much less activity against unrelated RTKs, soluble tyrosine kinases, or serine/threonine kinases. Linifanib is a specific miR-10b inhibitor that blocks miR-10b biogenesis .
loading...
    loading...
5
5 Cited Publications
Referencia número: HY-10202
No. CAS: 387867-13-2
Pureza:  99.48%
Synonyms: MLN518; CT53518
Target:  

FLT3 c-Kit PDGFR Apoptosis

Áreas de investigación:  

Cancer

Tandutinib (MLN518) is a potent and selective inhibitor of the FLT3 with an IC50 of 0.22 μM, and also inhibits c-Kit and PDGFR with IC50s of 0.17 μM and 0.20 μM, respectively. Tandutinib can be used for acute myelogenous leukemia (AML) . Tandutinib has the ability to cross the blood-brain barrier .
loading...
    loading...
5
5 Cited Publications
Referencia número: HY-10202A
No. CAS: 2438900-70-8
Pureza:  99.78%
Synonyms: MLN518 hydrochloride; CT53518 hydrochloride
Target:  

FLT3 c-Kit PDGFR Apoptosis

Áreas de investigación:  

Cancer

Tandutinib hydrochloride (MLN518 hydrochloride) is a potent and selective inhibitor of the FLT3 with an IC50 of 0.22 μM, and also inhibits c-Kit and PDGFR with IC50s of 0.17 μM and 0.20 μM, respectively. Tandutinib hydrochloride can be used for acute myelogenous leukemia (AML) . Tandutinib hydrochloride has the ability to cross the blood-brain barrier .
loading...
    loading...
5
5 Cited Publications
Referencia número: HY-B0642
No. CAS: 16051-77-7
Synonyms: Isosorbide-5-mononitrate
Isosorbide mononitrate (Isosorbide-5-mononitrate) is an orally active nitric acid compound used for angina pectoris by dilating blood vessels and lowering blood pressure. Isosorbide mononitrate increases the viability and proliferation of HUVECs by decreasing Apoptosis and elevated the expressions of vedf, kdrl, pdgfr in zebrafish embryos. Isosorbide mononitrate is promising for research of heart failure and coronary heart disease .
loading...
    loading...
5
5 Cited Publications
Referencia número: HY-10209
No. CAS: 790299-79-5
Pureza:  99.95%
Synonyms: AB1010
Áreas de investigación:  

Cancer

Masitinib (AB1010) is a potent, orally bioavailable, and selective inhibitor of c-Kit (IC50=200 nM for human recombinant c-Kit). It also inhibits PDGFRα/β (IC50s=540/800 nM), Lyn (IC50= 510 nM for LynB), Lck, and, to a lesser extent, FGFR3 and FAK. Masitinib (AB1010) has anti-proliferative, pro-apoptotic activity and low toxicity .
loading...
    loading...
5
5 Cited Publications
Referencia número: HY-10209A
No. CAS: 1048007-93-7
Pureza:  99.51%
Synonyms: AB-1010 mesylate
Target:  

c-Kit PDGFR Src FGFR Apoptosis

Áreas de investigación:  

Cancer

Masitinib mesylate (AB-1010 mesylate) is a potent, orally bioavailable, and selective inhibitor of c-Kit (IC50=200 nM for human recombinant c-Kit). It also inhibits PDGFRα/β (IC50s=540/800 nM), Lyn (IC50= 510 nM for LynB), Lck, and, to a lesser extent, FGFR3 and FAK. Masitinib mesylate (AB-1010 mesylate) has anti-proliferative, pro-apoptotic activity and low toxicity .
loading...
    loading...
4
4 Cited Publications
Referencia número: HY-101957
No. CAS: 71897-07-9
Pureza:  99.86%
Target:  

PDGFR

Áreas de investigación:  

Cardiovascular Disease

AG 1295 is a selective platelet-derived growth factor receptor (PDGFR) tyrosine-kinase inhibitor. AG1295 abolishes autophosphorylation of the PDGFR whereas not affects the autophosphorylation of the EGF receptor .
loading...
    loading...
4
4 Cited Publications
Referencia número: HY-10372
No. CAS: 1092788-83-4
Pureza:  99.51%
Target:  

mTOR PDGFR VEGFR Src Apoptosis

Áreas de investigación:  

Cancer

PP121 is a multi-targeted kinase inhibitor with IC50s of 10, 60, 12, 14, 2 nM for mTOR, DNK-PK, VEGFR2, Src, PDGFR, respectively.
loading...
    loading...